Pfizer Reports Strong Second-Quarter 2025 Results And Raises 2025 EPS Guidance
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 6/24/2026
- Wall Street ends lower on semiconductor selloff as AI spending concerns mount
- Alphabet added to Dow Jones Industrial Average, Verizon dropped
- Chip stocks plunge, but bargain-hunters limit scale of tech rout
- FedEx falls 4% as CY2026 profit forecast misses expectations despite Q4 beat
- Oil prices finish 1% lower as investors focus on Hormuz flows after peace talks
- Needham Starts NeoVolta (NEOV) at Buy
- NextEra to discuss paying about $76 per share for Dominion, Bloomberg News reports
- Wall Street ends lower on semiconductor selloff as AI spending concerns mount
- Campbell Soup (CPB) Declares $0.39 Quarterly Dividend; 7.7% Yield
- KKR launches Helix with over $10 billion to build AI infrastructure
Pfizer (PFE) Tops Q2 EPS by 21c, Beats on Revenue; Offers FY25 EPS Guidance
August 5, 2025 6:47 AM EDTPfizer (NYSE: PFE) reported Q2 EPS of $0.78, $0.21 better than the analyst estimate of $0.57. Revenue for the quarter came in at $14.7 billion versus the consensus estimate of $13.47 billion.
GUIDANCE:
Pfizer sees FY2025 EPS of $2.90-$3.10, versus the consensus of $3.01.
For earnings history and earnings-related data on Pfizer (PFE) click here.
... More